JESSICA YOUNG: Open Payments
NPI 1598133670 · EAST CHINA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 47 payments from 13 companies in 2025. Trend: 2023 $680 · 2024 $408 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $227 |
| Novo Nordisk Inc | 9 | $147 |
| Lilly USA, LLC | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Lundbeck LLC | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| ABBVIE INC. | 3 | $60 |
| Alkermes, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REXULTI, Rybelsus, MOUNJARO, XIFAXAN, CAPLYTA, QULIPTA, Wegovy, LYBALVI.
Industry payments across MI — which companies pay providers there.
